Left Main Revascularization: 12 Year Registry in Canada

The current indication for severe left main lesion continues to be coronary artery bypass graft surgery (CABG) but percutaneous coronary intervention (PCI) has come far in this territory thanks to increasing operator experienced and the use of IVUS during procedures.  

tronco de la coronaria izquierda

At present, left main disease have a Class IIa indication in the American guidelines when revascularization will be comparable to surgery, and the European guidelines indicate Class I with low complexity coronary anatomy and Class II with intermediate complexity.

Even though there is good information from important randomized studies with 3 to 5 year followup, it seldom reflects real world data, but we find different registries comparing both strategies. 

This is a retrospective analyzis carried out in Ontario, Canada, between October 2008 and 2020 from patients presenting severe left main lesion receiving revascularization within 90 days.

It included 2526 patients undergoing PCI and 21287 receiving CABG. Over time, the number of PCI patients increased, while CABG decreased. 

Read also: Intracardiac Echocardiography to Guide Watchman Left Atrial Appendix Closure: Safe and Effective?

The populations were different: PCI patients were older, were more often women, had more acute coronary syndrome and more comorbidities. 

Populations were therefore matched with propensity score, leaving 1128 patients in each group. 

There were no differences in hospital or early mortality, (3.7% vs 3.8% y 5.5% vs 3.9%) when comparing PCI against CABG. Neither were there differences in stroke, but there was higher MI rate among PCI patients. (2.7% vs 1.2% P =0.007). 

Read also: FLASH Registry: Mechanical Thrombectomy with FlowTriever.

At 7 year followup, all-cause mortality (53.6% vs 35.2%; HR: 1.63; 95% CI: 1.42-1.87; P < 0.001) and MACCE (66.8% vs 48.6%; HR: 1.77; 95% CI: 1.57-2.00), were higher among PCI patients vs. CABG. Also, PCI saw higher MI rate (10.6% vs. 19.3% 95% CI: 1.77-2.91P>0.0001) and need for repeat revascularization (18.4% vs 6.4% HR: 3.09; 95% CI: 2.31-4.16; P < 0.0001), it was also associated to higher stroke rate (5.3% vs 7.6% HR of 0.61 (95% CI: 0.42-0.89; P < 0.001).

Conclusion

CABG was the most common revascularization procedure in this “real world” registry. Those undergoing PCI were older and had higher risk. After propensity score matching, there were no differences in early mortality but survival and freedom from cardiac and cerebrovascular events were better with CABG. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the editorial board of SOLACI.org.

Original Title: Real-World Examination of Revascularization Strategies for Left Main Coronary Disease in Ontario, Canada.

Reference: Derrick Y. Tam, et al J Am Coll Cardiol Intv 2023;16:277–288.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...